Clinical Trial Update: Comparison Between Local Radiotherapy Alone or Combined With Obinutuzumab in Early Stage Follicular Lymphoma: the GAZEBO Trial From the Fondazione Italiana Linfomi [Phase 3]

View source ↗

Summary

Phase 3 trial investigating local radiotherapy alone versus radiotherapy combined with obinutuzumab in early-stage follicular lymphoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Obinutuzumab (obinutuzumab)

Snippet

Sponsor: Fondazione Italiana Linfomi - ETS | Conditions: Follicular Lymphoma | Phase 3 | Status: RECRUITING